Gene Biotherapeutics, Inc. Cash
Gene Biotherapeutics, Inc. had Cash of $400 as of 2019-12-31, per its 10-K filed 2021-04-23.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2021-04-23
- 2019-12-31: Cash $400.00.
- 2018-12-31: Cash $82.11K.
- 2017-12-31: Cash $48.99K.
| Period end | Cash |
|---|---|
| 2019-12-31 | $400.00 10-K · filed 2021-04-23 |
| 2018-12-31 | $82.11K 10-K · filed 2021-04-23 |
| 2017-12-31 | $48.99K 10-K · filed 2021-04-23 |